Form 4 · Filed May 28, 2026, 11:10 PM UTC
GLUE/Monte Rosa Therapeutics, Inc.
Champoux Jennifer — Chief Operating Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 27, 2026 | M | other | 2,175 | $4 | $8,657 | 64,546 |
| May 27, 2026 | S | sell | 2,175 | $20 | $43,500 | 62,371 |
| May 27, 2026 | M | other | 2,175 | — | — | 35,649 |
Source: SEC EDGAR raw filing ↗ · Accession 0001193125-26-245728